TB
Theravance Biopharma, Inc. (TBPH)
NASDAQ·Healthcare·Biotechnology
$16.68
-0.09%
Mkt Cap $857.84M
Analyst Ratings
Buy
5
Hold
3
Sell
0
Price Target (7 analysts)
$27.00
Range $14.00 – $40.00
Implied Upside
+61.9%
Consensus $27.00 vs current $16.68
NASDAQ·Healthcare·Biotechnology
$16.68
-0.09%
Mkt Cap $857.84M
Buy
5
Hold
3
Sell
0
Price Target (7 analysts)
$27.00
Range $14.00 – $40.00
+61.9%
Consensus $27.00 vs current $16.68